Rectal Cancer
INCA033890-303: A Randomized, Double-Blind, Phase 3 Study of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Details
ClinicalTrials.gov ID:
NCT07284849
Diagnosis Type:
NA
USOR Number:
- Address
,
P: